- $10.22bn
- $13.56bn
- $12.39bn
- 65
- 92
- 87
- 95
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 12,024 | 13,162 | 12,008 | 11,984 | 12,386 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10,465 | 12,010 | 10,562 | 10,046 | 10,551 |
Operating Profit | 1,560 | 1,152 | 1,446 | 1,939 | 1,835 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,382 | 964 | 1,261 | 1,750 | 1,640 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,100 | 793 | 981 | 1,407 | 1,284 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,100 | 793 | 981 | 1,407 | 1,284 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,100 | 793 | 981 | 1,407 | 1,284 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.44 | 4.04 | 5.1 | 6.98 | 6.5 |
Dividends per Share |